ECOR1 CAPITAL, LLC sold 39.0% of their position (64.05M shares) of ADAPTIMMUNE THERAPEUTICS PLC on the open market
Open‑market sale worth $6.89M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/30/2025ACC: 0000935836-25-000476
10% Owner
Since Mar 2024
-64.05M
Net shares
Net seller
$6.89M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
64.05M disposed
Non-Derivative Transactions3
Ordinary Shares
Indirect
Shares
−33.93M
Price / share
$0.11
Trade value
$3.82M
% of position
20.6%
7/28/2025
164.42M→130.49M
Ordinary Shares
Indirect
Shares
−2.69M
Price / share
$0.10
Trade value
$271.97K
% of position
2.1%
7/29/2025
130.49M→127.81M
Ordinary Shares
Indirect
Shares
−27.43M
Price / share
$0.10
Trade value
$2.80M
% of position
21.5%
7/30/2025
127.81M→100.37M
Total
Net shares
−64.05M
Net value
-$6.89M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 7/28/2025 | S · Sale | −33.93M | $0.11 | $3.82M | 20.6% | 164.42M | 130.49M |
| Ordinary Shares Indirect | 7/29/2025 | S · Sale | −2.69M | $0.10 | $271.97K | 2.1% | 130.49M | 127.81M |
| Ordinary Shares Indirect | 7/30/2025 | S · Sale | −27.43M | $0.10 | $2.80M | 21.5% | 127.81M | 100.37M |
| Total | −64.05M | -$6.89M | ||||||
Derivative Transactions0
No derivative transactions reported